Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.2200
+0.0050 (2.33%)
Mar 4, 2026, 3:03 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 27.62 million as of March 4, 2026. Its market cap has decreased by -73.22% in one year.
Market Cap
27.62M
Enterprise Value
22.58M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.22
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 27.62M, an increase of 45.17%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 27.62M | -27.12% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prescient Therapeutics | 71.50M |
| Neurizon Therapeutics | 63.35M |
| Amplia Therapeutics | 61.57M |
| Proteomics International Laboratories | 56.16M |
| Entropy Neurodynamics | 54.87M |
| NeuroScientific Biopharmaceuticals | 34.92M |
| Avecho Biotechnology | 33.06M |
| Algorae Pharmaceuticals | 29.03M |